We hypothesized that orally administered simvastatin in patients with endometriosis might reduce serum MCP-1, endometriosis-associated MCP-1, and cluster of differentiation-68 (CD68), a surface marker for macrophages, expression. The gene discussed is CD68; the disease is endometriosis.